4.6 Article

Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice

Related references

Note: Only part of the references are listed.
Article Oncology

Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis

Kavita Bhalla et al.

CANCER PREVENTION RESEARCH (2012)

Article Endocrinology & Metabolism

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Silvio E. Inzucchi et al.

DIABETES CARE (2012)

Review Endocrinology & Metabolism

Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Zhi-Jiang Zhang et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Oncology

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

Andrea DeCensi et al.

CANCER PREVENTION RESEARCH (2010)

Review Oncology

Metformin: Taking away the candy for cancer?

Mathilde Jalving et al.

EUROPEAN JOURNAL OF CANCER (2010)

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection

Brad Q. Starley et al.

HEPATOLOGY (2010)

Article Biochemistry & Molecular Biology

Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase

Kunihiro Hosono et al.

MOLECULAR CARCINOGENESIS (2010)

Article Biochemistry & Molecular Biology

Diet-induced hepatocellular carcinoma in genetically predisposed mice

Annie E. Hill-Baskin et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese

Chong Yew Tan et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2008)

Article Multidisciplinary Sciences

Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome

May-Yun Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Asmaa Ibrahim Gomaa et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Article Endocrinology & Metabolism

Adipocyte death, adipose tissue remodeling, and obesity complications

Katherine J. Strissel et al.

DIABETES (2007)

Article Endocrinology & Metabolism

Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes

P. J. English et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)

Article Gastroenterology & Hepatology

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

S Nair et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)

Review Physiology

The physiology of cellular liporegulation

RH Unger

ANNUAL REVIEW OF PHYSIOLOGY (2003)

Article Genetics & Heredity

Molecular pathogenesis of human hepatocellular carcinoma

SS Thorgeirsson et al.

NATURE GENETICS (2002)

Article Medicine, General & Internal

Metformin in non-alcoholic steatohepatitis

G Marchesini et al.

LANCET (2001)

Article Biochemistry & Molecular Biology

Metformin reverses fatty liver disease in obese, leptin-deficient mice

HZ Lin et al.

NATURE MEDICINE (2000)